Historical record - last NADAC effective date: 8/17/2016
Product Information
NALOXONE 0.4 MG/ML VIAL is a generic product labeled by Hospira Inc., priced at $15.7839 per ML under NDC 00409121901. Its NADAC has been published 87 times since Dec 23, 2015.
FDA first approved this application on Jan 7, 1987. Its Orange Book therapeutic-equivalence code is AP.
Strength
.4 mg/mL
Manufacturer
Hospira Inc.NDC
00409121901
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Effective Date
8/17/2016
Active Ingredients
NALOXONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070257FDA Approved
1/7/1987
TE Code
AP
On Market Since
9/2/2005
Pharmacological Classes
Price Statistics
The NADAC for NALOXONE 0.4 MG/ML VIAL has been published 87 times since Dec 23, 2015, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.7839 per ML |
|---|---|
| All-time high | $15.7839 (Aug 16, 2017) |
| All-time low | $15.0287 (Dec 23, 2015) |
| Median price | $15.7839 |
| Average price | $15.5164 |
| Largest weekly change | +4.0% (Jul 20, 2016) |
| Weeks tracked | 87 |
| Tracking since | Dec 23, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+5.0%
Last surveyed Aug 16, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hospira Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NALOXONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NALOXONE 0.4 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for NALOXONE 0.4 MG/ML VIAL, manufactured by Hospira Inc., is $15.7839 per ML (NDC 00409121901), effective Aug 16, 2017.
How has the price of NALOXONE 0.4 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for NALOXONE 0.4 MG/ML VIAL has risen 5.0%. It has been tracked across 87 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for NALOXONE 0.4 MG/ML VIAL?
Since Dec 23, 2015, the NADAC for NALOXONE 0.4 MG/ML VIAL has ranged from a low of $15.0287 (Dec 23, 2015) to a high of $15.7839 (Aug 16, 2017), with a median of $15.7839 per ML.
Are there cheaper alternatives to NALOXONE 0.4 MG/ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NALOXONE 4 MG/10 ML VIAL, is $3.8243 per ML — about 76% below NALOXONE 0.4 MG/ML VIAL.
Who manufactures NALOXONE 0.4 MG/ML VIAL?
NALOXONE 0.4 MG/ML VIAL (NDC 00409121901) is labeled by Hospira Inc., and CMS classifies it as a generic product.